Potential assets would target multiple biological pathways in a single molecule Total value of the partnership potentially exceeds $1 billion if multiple assets advance WESTON, Mass., Oct. 29, 2025 ...
First patient dosed in Phase 1/2a study with novel immune rejuvenator, a trispecific antibody-fusion protein Two MDX2004 abstracts accepted for poster presentation at SITC Annual Meeting 2025 WESTON, ...
US biotech Regeneron Pharmaceuticals (Nasdaq: REGN) has entered a license and collaboration deal with OPKO Health’s (Nasdaq: ...
Regeneron and ModeX Therapeutics have joined forces in a collaboration worth over one billion dollars to develop ...
ModeX Therapeutics enters research collaboration with Regeneron to develop multispecific antibodies for select therapeutic indications: Weston, Massachusetts Thursday, October 30, ...
Chris Planto has rejoined Rate as VP of mortgage lending in Houston after serving as a senior loan officer at CrossCountry ...
Zacks Investment Research on MSN
OPK Q3 Earnings Beat Estimates, Sales Miss, Gross Margin Expands
OPKO Health, Inc. OPK posted earnings per share of 3 cents for the third quarter of 2025, flat year over year. Earnings beat ...
The United States and China appear to have found at least some common ground on a few different issues, during this week’s meeting between President Donald Trump and President of the People’s Republic ...
Swiss generics and biosimilars drugmaker Sandoz today presented its net-sales performance for the nine months and third ...
The Federal Reserve said yesterday that it lowered the target rate, for the federal funds rate, which comes from its Federal Open Market Committee (FOMC) for the second consecutive month, dropping it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback